SlowMo trial: a digital therapy for people who fear harm from others

Not Applicable

Completed

• Conditions: Paranoia; Mental and Behavioural Disorders; Delusional disorder

• Registration Number: ISRCTN32448671
• Lead Sponsor: King's College London

Brief Summary

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29096681 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33825827/ (added 08/04/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35776506/ (added 04/07/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-02-02
• Study Completion: 2019-10-25
• Last Update Posted: 20 June 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 362

Inclusion Criteria

1. Aged 18 years and over
2. Persistent (3+ months) distressing paranoia (as assessed using clinical interview (SCAN) and score >29 on Green Paranoid Thoughts Scale (GPTS), persecutory subscale)
3. Diagnosis of schizophrenia-spectrum psychosis (F20-29, ICD 10: Present State Examination, version 10)
4. Capacity to provide informed consent
5. Sufficient grasp of English to participate in informed consent process, assessments and interventions

Exclusion Criteria

1. Lacks capacity to consent
2. Profound visual and/ or hearing impairment
3. Insufficient comprehension of English
4. Inability to engage in the assessment procedure
5. Engagement in psychological therapy for paranoia
6. Primary diagnosis of substance abuse disorder, personality disorder, organic syndrome or learning disability

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Paranoia is assessed using the Green Paranoid Thoughts Scale (GPTS) at screening, baseline, 12 weeks and 24 weeks.